Table 3.
ILIB rs1143633 genotypes and allelic variants of ET patients and controls
| rs1143633 | All ET patients (n = 225) | Controls (n = 229) | ET patients without concomitant RLS (n = 200) |
|---|---|---|---|
| SNP Call rate | 97.3% | 99.1% | 97.5% |
| Genotypes | |||
| GG | 38 (17.4%) | 17 (7.5%) | 33 (16.9%) |
| GA | 95 (43.4%) | 120 (52.9%) | 84 (43.1%) |
| AA | 86 (39.2%) | 90 (39.6%) | 78 (40.0%) |
| Alleles | |||
| G | 171 (39.0%) | 154 (33.9%) | 150 (38.5%) |
| A | 267 (61.0%) | 300 (66.1%) | 240 (61.5%) |
| Recessive model | |||
| GG | 38 (15.1%) | 17 (7.5%) | 33 (16.9%) |
| AA+GA | 181 (84.9%) | 210 (92.5%) | 162 (83.1%) |
The values in each cell represent: number (percentage)